INTERNATIONAL PATENT: LG CHEM, LTD., RHYTHM PHARMACEUTICALS, INC., PARK, HEE, DONG, HWANG, HYE, KYEONG FILES APPLICATION FOR "USE OF MELANOCORTIN-4 RECEPTOR AGONISTS FOR THE TREATMENT OF A LEPR AND/OR SH2B1 DEFICIENCY"

GENEVA, July 10 -- LG CHEM, LTD. (128, Yeoui-daeroYeongdeungpo-guSeoul07336), RHYTHM PHARMACEUTICALS, INC. (222 Berkeley Street, 12th FloorBoston, MA 02116), PARK, Hee, Dong (C/o Lg Chem, Ltd.128, Yeoui-daeroYeongdeungpo-guSeoul07336), HWANG, Hye, Kyeong (C/o Lg Chem, Ltd.128, Yeoui-daeroYeongdeungpo-guSeoul07336) filed a patent application (PCT/US2024/061918) for "USE OF MELANOCORTIN-4 RECEPTOR AGONISTS FOR THE TREATMENT OF A LEPR AND/OR SH2B1 DEFICIENCY" on Dec 26, 2024. With publication no. WO/2025/144899, the details related to the patent application was published on Jul 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property...